Company
Discgenics
To improve the lives of those debilitated by degenerative diseases of the spine through innovative regenerative therapies.
Also known as DiscGenics, Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Salt Lake City, UT, United States
- Legal name
- DiscGenics, Inc.
- discgenics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based biologic drug therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.
Funding snapshot
- Total raised
- $1.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round2013-05-16
Funding rounds
- Round, 2013
- 2013-05-16
- Round, 2010
- $1.8M2010-08-16, SEC form D sold, 17 investors
Products
- Other
- IDCT (rebonuputemcel)
Loading relationship preview